- Home
- EONR vs BFRI Comparison
EONR vs BFRI Comparison
Compare EONR & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EONR
- BFRI
- Stock Information
- Founded
- EONR 2017
- BFRI 1997
- Country
- EONR United States
- BFRI United States
- Employees
- EONR N/A
- BFRI N/A
- Industry
- EONR
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- EONR
- BFRI Health Care
- Exchange
- EONR NYSE
- BFRI Nasdaq
- Market Cap
- EONR 6.8M
- BFRI 7.5M
- IPO Year
- EONR N/A
- BFRI 2021
- Fundamental
- Price
- EONR $0.35
- BFRI $0.62
- Analyst Decision
- EONR Strong Buy
- BFRI Strong Buy
- Analyst Count
- EONR 1
- BFRI 1
- Target Price
- EONR $2.00
- BFRI $2.75
- AVG Volume (30 Days)
- EONR 15.3M
- BFRI 188.7K
- Earning Date
- EONR 08-15-2025
- BFRI 08-13-2025
- Dividend Yield
- EONR N/A
- BFRI N/A
- EPS Growth
- EONR N/A
- BFRI N/A
- EPS
- EONR N/A
- BFRI N/A
- Revenue
- EONR $19,638,616.00
- BFRI $37,997,000.00
- Revenue This Year
- EONR $46.94
- BFRI $11.75
- Revenue Next Year
- EONR $64.38
- BFRI $17.09
- P/E Ratio
- EONR N/A
- BFRI N/A
- Revenue Growth
- EONR N/A
- BFRI 14.28
- 52 Week Low
- EONR $0.34
- BFRI $0.54
- 52 Week High
- EONR $2.92
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- EONR N/A
- BFRI 45.79
- Support Level
- EONR N/A
- BFRI $0.61
- Resistance Level
- EONR N/A
- BFRI $0.66
- Average True Range (ATR)
- EONR 0.00
- BFRI 0.05
- MACD
- EONR 0.00
- BFRI 0.00
- Stochastic Oscillator
- EONR 0.00
- BFRI 35.00
About EONR EON RESOURCES INC
EON Resources Inc is an independent upstream energy company focused on maximizing total returns to its shareholders through the development of onshore oil and natural gas properties in the United States. Its current focus is as an upstream energy company producing oil and gas properties in the Permian Basin.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.